Recent advances in the engineering of nanosized active pharmaceutical ingredients: Promises and challenges.
暂无分享,去创建一个
[1] K. Amighi,et al. Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[2] S. Baumgartner,et al. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs. , 2006, International journal of pharmaceutics.
[3] Abu T M Serajuddin,et al. Salt formation to improve drug solubility. , 2007, Advanced drug delivery reviews.
[4] K. Johnston,et al. Rapid Expansion from Supercritical to Aqueous Solution to Produce Submicron Suspensions of Water‐Insoluble Drugs , 2000, Biotechnology progress.
[5] Brian G Trewyn,et al. Mesoporous silica nanomaterial-based biotechnological and biomedical delivery systems. , 2007, Nanomedicine.
[6] E. Reverchon,et al. Supercritical fluids applications in nanomedicine , 2015 .
[7] Kiyohiko Sugano,et al. Possible reduction of effective thickness of intestinal unstirred water layer by particle drifting effect. , 2010, International journal of pharmaceutics.
[8] R. Müller,et al. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. , 2004, International journal of pharmaceutics.
[9] Y. M. Rao,et al. Formulation of Nanosuspensions of Albendazole for Oral Administration , 2008 .
[10] S. Gour,et al. Manufacturing Nanosized Fenofibrate by Salt Assisted Milling , 2009, Pharmaceutical Research.
[11] Jeffrey W Card,et al. Pulmonary applications and toxicity of engineered nanoparticles. , 2008, American journal of physiology. Lung cellular and molecular physiology.
[12] R. Müller,et al. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. , 2002, Advanced drug delivery reviews.
[13] H. Uchida,et al. Production of theophylline nanoparticles using rapid expansion of supercritical solutions with a solid cosolvent (RESS-SC) technique , 2015 .
[14] G Vergnault,et al. Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug. , 2007, Advanced drug delivery reviews.
[15] G. Liversidge,et al. Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats , 1995 .
[16] Anna Nordmark,et al. A formulation comparison between micro- and nanosuspensions: the importance of particle size for absorption of a model compound, following repeated oral administration to rats during early development , 2011, Drug development and industrial pharmacy.
[17] Sanjay Garg,et al. Effect of wet milling process on the solid state of indomethacin and simvastatin. , 2009, International journal of pharmaceutics.
[18] Y. Kawashima,et al. Engineering of poly(DL-lactic-co-glycolic acid) nanocomposite particles for dry powder inhalation dosage forms of insulin with the spray-fluidized bed granulating system , 2007 .
[19] A. Badawi,et al. Formulation and Stability Testing of Itraconazole Crystalline Nanoparticles , 2011, AAPS PharmSciTech.
[20] Siling Wang,et al. Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation , 2012, Drug development and industrial pharmacy.
[21] Li Yang,et al. Rod shaped nanocrystals exhibit superior in vitro dissolution and in vivo bioavailability over spherical like nanocrystals: a case study of lovastatin. , 2015, Colloids and surfaces. B, Biointerfaces.
[22] Kikuo Okuyama,et al. Control of the morphology of nanostructured particles prepared by the spray drying of a nanoparticle sol. , 2003, Journal of colloid and interface science.
[23] K. Amighi,et al. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. , 2005, International journal of pharmaceutics.
[24] C. Barbé,et al. Silica Particles: A Novel Drug‐Delivery System , 2004 .
[25] I. Ghosh,et al. Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth. , 2011, International journal of pharmaceutics.
[26] Jonghwi Lee,et al. Redispersible drug nanoparticles prepared without dispersant by electro-spray drying , 2012, Drug development and industrial pharmacy.
[27] Huixia Lv,et al. Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal. , 2011, International journal of pharmaceutics.
[28] T. De Beer,et al. Formulation of itraconazole nanococrystals and evaluation of their bioavailability in dogs. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[29] Moritz Beck-Broichsitter,et al. Characterization of novel spray-dried polymeric particles for controlled pulmonary drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[30] S. Onoue,et al. Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability. , 2010, Journal of pharmaceutical sciences.
[31] E. Souto,et al. Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound. , 2011, Colloids and surfaces. B, Biointerfaces.
[32] K. Moribe,et al. Co-grinding with Cyclodextrin as a Nanoparticle Preparation Method of a Poorly Water Soluble Drug , 2004 .
[33] R. Cavalli,et al. Drug nanosuspensions: a ZIP tool between traditional and innovative pharmaceutical formulations , 2015, Expert opinion on drug delivery.
[34] S. Stainmesse,et al. Freeze-drying of nanoparticles: formulation, process and storage considerations. , 2006, Advanced drug delivery reviews.
[35] Jianfeng Chen,et al. Production of salbutamol sulfate for inhalation by high-gravity controlled antisolvent precipitation. , 2007, International journal of pharmaceutics.
[36] Cordin Arpagaus,et al. Nanoparticles by spray drying using innovative new technology: the Büchi nano spray dryer B-90. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[37] Qiang Zhang,et al. Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats. , 2001, International journal of pharmaceutics.
[38] Rainer H. Müller,et al. Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique , 1998 .
[39] R. Müller,et al. Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability. , 2002, International journal of pharmaceutics.
[40] Chang Ming Li,et al. Solubility enhancement of a poorly water-soluble anti-malarial drug: experimental design and use of a modified multifluid nozzle pilot spray drier. , 2009, Journal of pharmaceutical sciences.
[41] M. Sugimoto,et al. Improvement of dissolution characteristics and bioavailability of poorly water-soluble drugs by novel cogrinding method using water-soluble polymer , 1998 .
[42] G. Liversidge,et al. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs , 1995 .
[43] Michael Türk,et al. Micronization of pharmaceutical substances by the Rapid Expansion of Supercritical Solutions (RESS): a promising method to improve bioavailability of poorly soluble pharmaceutical agents , 2002 .
[44] Christos Reppas,et al. Biorelevant in vitro dissolution testing of products containing micronized or nanosized fenofibrate with a view to predicting plasma profiles. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[45] C. Remuñán-López,et al. Microencapsulated chitosan nanoparticles for lung protein delivery. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[46] Vijay Kumar,et al. Cyclodextrin complexation: influence on the solubility, stability, and cytotoxicity of camptothecin, an antineoplastic agent. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[47] Amrit Paudel,et al. Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations. , 2013, International journal of pharmaceutics.
[48] M. Márquez,et al. Micro/Nano Encapsulation via Electrified Coaxial Liquid Jets , 2002, Science.
[49] Jing Wang,et al. Mesoporous Silica‐Coated Gold Nanorods as a Light‐Mediated Multifunctional Theranostic Platform for Cancer Treatment , 2012, Advanced materials.
[50] Rainer H Müller,et al. Development of an oral rutin nanocrystal formulation. , 2009, International journal of pharmaceutics.
[51] E. Merisko-Liversidge,et al. Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds , 2008, Toxicologic pathology.
[52] W. Wildeboer,et al. Study of the process of stirred ball milling of poorly water soluble organic products using factorial design , 2010 .
[53] Jennifer Jung,et al. Particle design using supercritical fluids: Literature and patent survey , 2001 .
[54] S. Gour,et al. Deaggregation of nanodiamond powders using salt- and sugar-assisted milling. , 2010, ACS applied materials & interfaces.
[55] E. Cesari,et al. Amorphization of organic compounds by ball milling , 1997 .
[56] Herbert Freundlich,et al. Colloid and capillary chemistry , 1922 .
[57] K. Higashi,et al. Prednisolone multicomponent nanoparticle preparation by aerosol solvent extraction system. , 2009, International journal of pharmaceutics.
[58] Sadhna Sharma,et al. Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis. , 2005, International journal of antimicrobial agents.
[59] V. Mohanraj,et al. Nanoparticles - A Review , 2007 .
[60] Jing Ma,et al. Preparation of a chemically stable quercetin formulation using nanosuspension technology. , 2011, International journal of pharmaceutics.
[61] Indrajit Ghosh,et al. Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[62] K. Eid,et al. Nanosized rods agglomerates as a new approach for formulation of a dry powder inhaler , 2011, International journal of nanomedicine.
[63] F. Vrečer,et al. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs , 2013, Acta pharmaceutica.
[64] Huibi Xu,et al. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility. , 2011, International journal of pharmaceutics.
[65] R. Wiwattanapatapee,et al. Preparation and evaluation of Bacillus megaterium-alginate microcapsules for control of rice sheath blight disease , 2013, World journal of microbiology & biotechnology.
[66] D. Lamprou,et al. Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility , 2011, Journal of microencapsulation.
[67] Hongwei Wang,et al. Paclitaxel nanosuspensions coated with P-gp inhibitory surfactants: I. Acute toxicity and pharmacokinetics studies. , 2013, Colloids and surfaces. B, Biointerfaces.
[68] B. Sarmento,et al. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. , 2007, Drug discovery today.
[69] J. Remon,et al. An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen. , 2001, International journal of pharmaceutics.
[70] Hirst,et al. Development of a new engineering-based capsule for human drug absorption studies. , 2000, Pharmaceutical science & technology today.
[71] A. Mujumdar. Handbook of Industrial Drying , 2020 .
[72] Yuan Le,et al. Preparation of ultrafine beclomethasone dipropionate drug powder by antisolvent precipitation , 2007 .
[73] Jie-xin Wang,et al. Preparation of azithromycin nanosuspensions by reactive precipitation method , 2012, Drug development and industrial pharmacy.
[74] H. Okada,et al. Preparation of drug nanoparticle-containing microparticles using a 4-fluid nozzle spray drier for oral, pulmonary, and injection dosage forms. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[75] C. Berkland,et al. Nanoparticle formulations in pulmonary drug delivery , 2009, Medicinal research reviews.
[76] G. P. Martin,et al. Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[77] O. Corrigan. Thermal analysis of spray dried products , 1995 .
[78] R. Müller,et al. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. , 2001, Advanced drug delivery reviews.
[79] P. Chattopadhyay,et al. Production of griseofulvin nanoparticles using supercritical CO(2) antisolvent with enhanced mass transfer. , 2001, International journal of pharmaceutics.
[80] Jonghwi Lee,et al. Role of polymeric stabilizers for drug nanocrystal dispersions , 2005 .
[81] Jianfeng Chen,et al. Facile Preparation of Danazol Nanoparticles by High-Gravity Anti-solvent Precipitation (HGAP) Method , 2009 .
[82] Panos Macheras,et al. A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system. , 2006, International journal of pharmaceutics.
[83] J. M. Shaw,et al. Formulation and Antitumor Activity Evaluation of Nanocrystalline Suspensions of Poorly Soluble Anticancer Drugs , 1996, Pharmaceutical Research.
[84] Wei Yang,et al. Inhaled nanoparticles--a current review. , 2008, International journal of pharmaceutics.
[85] P. Chattopadhyay,et al. Production of Antibiotic Nanoparticles Using Supercritical CO2 as Antisolvent with Enhanced Mass Transfer , 2001 .
[86] E. Munson,et al. Budesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolution. , 2009, Journal of pharmaceutical sciences.
[87] K. Cal,et al. Spray drying technique: II. Current applications in pharmaceutical technology. , 2010, Journal of pharmaceutical sciences.
[88] H W Frijlink,et al. A novel bottom-up process to produce drug nanocrystals: controlled crystallization during freeze-drying. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[89] Kazutaka Higaki,et al. In vitro-in vivo correlation for wet-milled tablet of poorly water-soluble cilostazol. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[90] P Augustijns,et al. Characterization of physico-chemical properties and pharmaceutical performance of sucrose co-freeze-dried solid nanoparticulate powders of the anti-HIV agent loviride prepared by media milling. , 2007, International journal of pharmaceutics.
[91] Robert K. Schultz,et al. Process-Induced Crystallinity Changes in Albuterol Sulfate and Its Effect on Powder Physical Stability , 1995, Pharmaceutical Research.
[92] M. Odomi,et al. Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[93] K. Johnston,et al. Single dose and multiple dose studies of itraconazole nanoparticles. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[94] E. Merisko-Liversidge,et al. Insulin Nanoparticles: A Novel Formulation Approach for Poorly Water Soluble Zn-Insulin , 2004, Pharmaceutical Research.
[95] J E Kipp,et al. The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. , 2004, International journal of pharmaceutics.
[96] Biana Godin,et al. Biocompatibility assessment of Si-based nano- and micro-particles. , 2012, Advanced drug delivery reviews.
[97] Gloria Kwei,et al. The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human. , 2004, International journal of pharmaceutics.
[98] Y. Wang,et al. Fabrication of drug nanoparticles by evaporative precipitation of nanosuspension. , 2010, International journal of pharmaceutics.
[99] David A Groneberg,et al. Nanomedicine for respiratory diseases. , 2006, European journal of pharmacology.
[100] Karl-Ernst Wirth,et al. Electrostatically supported surface coating of solid particles in liquid nitrogen for use in Dry-Powder-Inhalers , 2003 .
[101] D A Weitz,et al. Trojan particles: Large porous carriers of nanoparticles for drug delivery , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[102] Patrick Augustijns,et al. Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. , 2008, International journal of pharmaceutics.
[103] K. Amighi,et al. Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery. , 2009, International journal of pharmaceutics.
[104] York,et al. Strategies for particle design using supercritical fluid technologies. , 1999, Pharmaceutical science & technology today.
[105] D. Traini,et al. The nanoscale in pulmonary delivery. Part 1: deposition, fate, toxicology and effects , 2007, Expert opinion on drug delivery.
[106] Jun Lin,et al. Functionalized mesoporous silica materials for controlled drug delivery. , 2012, Chemical Society reviews.
[107] W. Finlay,et al. Inertial sizing of aerosol inhaled from two dry powder inhalers with realistic breath patterns versus constant flow rates. , 2000, International journal of pharmaceutics.
[108] B. Pulliam,et al. Nanoparticles for drug delivery to the lungs. , 2007, Trends in biotechnology.
[109] Pardeep Gupta,et al. Effect of arginine hydrochloride and hydroxypropyl cellulose as stabilizers on the physical stability of high drug loading nanosuspensions of a poorly soluble compound. , 2008, International journal of pharmaceutics.
[110] Wenting Dai,et al. Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions. , 2008, International journal of pharmaceutics.
[111] Anjali Sharma,et al. Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis. , 2004, The Journal of antimicrobial chemotherapy.
[112] M. Mazzotti,et al. High pressure homogenization of pharmaceutical solids , 2012 .
[113] Elaine Merisko-Liversidge,et al. Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology. , 2011, Advanced drug delivery reviews.
[114] Barrett E. Rabinow,et al. Nanosuspensions in drug delivery , 2004, Nature Reviews Drug Discovery.
[115] Jukka Rantanen,et al. Quality by design approach in the optimization of the spray-drying process , 2012, Pharmaceutical development and technology.
[116] Jinming Gao,et al. Nanonization strategies for poorly water-soluble drugs. , 2011, Drug discovery today.
[117] Jennifer B Dressman,et al. Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[118] F. Donsì,et al. Preparation of curcumin sub-micrometer dispersions by high-pressure homogenization. , 2010, Journal of agricultural and food chemistry.
[119] Terry A. Ring,et al. Fundamentals of crystallization: Kinetic effects on particle size distributions and morphology , 1991 .
[120] Jean-Pierre Benoit,et al. Preparation of Poly(D,L-Lactide/Glycolide) Nanoparticles of Controlled Particle Size Distribution: Application of Experimental Designs , 1992 .
[121] M. Hussain,et al. Bioavailability enhancement of a COX-2 inhibitor, BMS-347070, from a nanocrystalline dispersion prepared by spray-drying. , 2005, Journal of pharmaceutical sciences.
[122] M. Bebawy,et al. Liposomal Nanoparticles Control the Uptake of Ciprofloxacin Across Respiratory Epithelia , 2012, Pharmaceutical Research.
[123] H. Schuchmann,et al. Influence of hydrostatic pressure and sound amplitude on the ultrasound induced dispersion and de-agglomeration of nanoparticles. , 2008, Ultrasonics sonochemistry.
[124] N. Rasenack,et al. Dissolution Rate Enhancement by in Situ Micronization of Poorly Water-Soluble Drugs , 2002, Pharmaceutical Research.
[125] Jianfeng Chen,et al. Engineering of drug nanoparticles by HGCP for pharmaceutical applications , 2008 .
[126] Jianjun Zhang,et al. Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[127] D. Mcclements,et al. Solid Lipid Nanoparticles as Delivery Systems for Bioactive Food Components , 2008 .
[128] Rajesh N. Dave,et al. Sub-100nm drug particle suspensions prepared via wet milling with low bead contamination through novel process intensification , 2015 .
[129] Jianfeng Chen,et al. Preparation and Characterization of Amorphous Cefuroxime Axetil Drug Nanoparticles with Novel Technology: High-Gravity Antisolvent Precipitation , 2006 .
[130] Erich Brunner,et al. Reaktionsgeschwindigkeit in heterogenen Systemen , 1904 .
[131] L. Galet,et al. Engineering of nano-crystalline drug suspensions: employing a physico-chemistry based stabilizer selection methodology or approach. , 2014, International journal of pharmaceutics.
[132] D. Lamprou,et al. Development of solid lipid nanoparticles for enhanced solubility of poorly soluble drugs. , 2010, Journal of biomedical nanotechnology.
[133] L. Froyen,et al. Drying of crystalline drug nanosuspensions-the importance of surface hydrophobicity on dissolution behavior upon redispersion. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[134] L. Froyen,et al. Microcrystalline cellulose, a useful alternative for sucrose as a matrix former during freeze-drying of drug nanosuspensions - a case study with itraconazole. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[135] R. Müller,et al. Production and Characterization of a Budesonide Nanosuspension for Pulmonary Administration , 2002, Pharmaceutical Research.
[136] J. Rieger,et al. Organic Nanoparticles in the Aqueous Phase-Theory, Experiment, and Use. , 2001, Angewandte Chemie.
[137] Rainer H. Müller,et al. Bottom-up approaches for preparing drug nanocrystals: formulations and factors affecting particle size. , 2013, International journal of pharmaceutics.
[138] Hirofumi Takeuchi,et al. Particle design of poorly water-soluble drug substances using supercritical fluid technologies. , 2008, Advanced drug delivery reviews.
[139] I. Ghosh,et al. Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: effect of Vitamin E TPGS and nanocrystal particle size on oral absorption. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[140] Siling Wang,et al. Nimodipine nanocrystals for oral bioavailability improvement: preparation, characterization and pharmacokinetic studies. , 2013, Colloids and surfaces. B, Biointerfaces.
[141] Ram B. Gupta,et al. Formation of phenytoin nanoparticles using rapid expansion of supercritical solution with solid cosolvent (RESS-SC) process. , 2006, International journal of pharmaceutics.
[142] R. Müller,et al. New method for the effective production of ultrafine drug nanocrystals. , 2006, Journal of nanoscience and nanotechnology.
[143] R. Bodmeier,et al. Incorporation of polymeric nanoparticles into solid dosage forms. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[144] R. Müller,et al. Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide. , 2000, International journal of pharmaceutics.
[145] R. Davé,et al. Redispersible fast dissolving nanocomposite microparticles of poorly water-soluble drugs. , 2014, International journal of pharmaceutics.
[146] Timo Laaksonen,et al. Electrospraying, spray drying and related techniques for production and formulation of drug nanoparticles , 2010, Expert opinion on drug delivery.
[147] F. Espitalier,et al. Liquid anti-solvent recrystallization to enhance dissolution of CRS 74, a new antiretroviral drug , 2015, Drug development and industrial pharmacy.
[148] Lai Yeng Lee,et al. Supercritical antisolvent production of biodegradable micro- and nanoparticles for controlled delivery of paclitaxel. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[149] N. Chew,et al. Novel alternative methods for the delivery of drugs for the treatment of asthma. , 2003, Advanced drug delivery reviews.
[150] D. Katti,et al. Electrospraying: a facile technique for synthesis of chitosan-based micro/nanospheres for drug delivery applications. , 2009, Journal of biomedical materials research. Part B, Applied biomaterials.
[151] Shohei Sugimoto,et al. Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[152] E. Kauppinen,et al. Aerosol flow reactor method for synthesis of drug nanoparticles. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[153] S. Jafari,et al. Optimization of nano-emulsions production by microfluidization , 2007 .
[154] A. Noyes,et al. The rate of solution of solid substances in their own solutions , 1897 .
[155] Rainer H Müller,et al. State of the art of nanocrystals--special features, production, nanotoxicology aspects and intracellular delivery. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[156] Hak-Kim Chan,et al. Feasibility of preparing nanodrugs by high-gravity reactive precipitation. , 2004, International journal of pharmaceutics.
[157] W. Friess,et al. Evaluation of the Nano Spray Dryer B-90 for pharmaceutical applications. , 2011, Pharmaceutical development and technology.
[158] V. Mykhaylova. DEVELOPMENT OF MICROPARTICLE - NANOPARTICLE POWDER MIXTURES FOR THE USE IN DRY POWDER INHALERS , 2009 .
[159] Michael Juhnke,et al. Accelerated Formulation Development for Nanomilled Active Pharmaceutical Ingredients Using a Screening Approach , 2010 .
[160] M. Descamps,et al. Direct crystal to glass transformation of trehalose induced by ball milling , 2001 .
[161] F. Cui,et al. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[162] Carmen Popescu,et al. Conversion of Nanosuspensions into Dry Powders by Spray Drying: A Case Study , 2008, Pharmaceutical Research.
[163] G. Van den Mooter,et al. Bead layering as a process to stabilize nanosuspensions: influence of drug hydrophobicity on nanocrystal reagglomeration following in‐vitro release from sugar beads , 2011, The Journal of pharmacy and pharmacology.
[164] D. Horn,et al. Preparation and Characterization of Nano-Sized Carotenoid Hydrosols , 1996 .
[165] Ulf Olsson,et al. Amorphous drug nanosuspensions. 3. Particle dissolution and crystal growth. , 2007, Langmuir : the ACS journal of surfaces and colloids.
[166] E. Reverchon,et al. Tailoring of nano- and micro-particles of some superconductor precursors by supercritical antisolvent precipitation , 2002 .
[167] Rainer H Müller,et al. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[168] J. Kreuter. Nanoparticles--a historical perspective. , 2007, International journal of pharmaceutics.
[169] Georg Achleitner,et al. Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[170] C. Nyström,et al. Physicochemical aspects of drug release. VIII. The relation between particle size and surface specific dissolution rate in agitated suspensions , 1988 .
[171] Malay K. Das,et al. Preparation and in vitro/in vivo evaluation of felodipine nanosuspension , 2013, European Journal of Drug Metabolism and Pharmacokinetics.
[172] Xun Wang,et al. Monodisperse nanocrystals: general synthesis, assembly, and their applications. , 2007, Chemical communications.
[173] Jianfeng Chen,et al. Preparation of amorphous cefuroxime axetil nanoparticles by controlled nanoprecipitation method without surfactants. , 2006, International journal of pharmaceutics.
[174] Niklas Sandler,et al. Improvement of dissolution rate of indomethacin by inkjet printing. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[175] E. Kauppinen,et al. Preparation of polymeric nanoparticles containing corticosteroid by a novel aerosol flow reactor method. , 2003, International journal of pharmaceutics.
[176] Yu Zhang,et al. Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung. , 2004, International journal of pharmaceutics.
[177] Fen Guo,et al. Synthesis of Nanoparticles with Novel Technology: High-Gravity Reactive Precipitation , 2000 .
[178] R. Tan,et al. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying. , 2011, International journal of pharmaceutics.
[179] D. Traini,et al. The nanoscale in pulmonary delivery. Part 2: formulation platforms , 2007, Expert opinion on drug delivery.
[180] T. A. Hatton,et al. Poly(ethylene oxide)-poly(propylene oxide )-poly (ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: thermodynamics, structure, dynamics, and modeling , 1995 .
[181] Yan Wang,et al. Development of a chemically stable 10-hydroxycamptothecin nanosuspensions. , 2009, International journal of pharmaceutics.
[182] Peter York,et al. Particle engineering using sonocrystallization: salbutamol sulphate for pulmonary delivery. , 2009, International journal of pharmaceutics.
[183] Helmut Hahn,et al. Atovaquone Nanosuspensions Show Excellent Therapeutic Effect in a New Murine Model of Reactivated Toxoplasmosis , 2001, Antimicrobial Agents and Chemotherapy.
[184] Joseph Wong,et al. Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat. , 2007, International journal of pharmaceutics.
[185] F. Kesisoglou,et al. Crystalline Nanosuspensions as Potential Toxicology and Clinical Oral Formulations for BCS II/IV Compounds , 2012, The AAPS Journal.
[186] W. Hinrichs,et al. Bottom-Up Preparation Techniques for Nanocrystals of Lipophilic Drugs , 2010, Pharmaceutical Research.
[187] Alejandro Sosnik,et al. Advantages and challenges of the spray-drying technology for the production of pure drug particles and drug-loaded polymeric carriers. , 2015, Advances in colloid and interface science.
[188] J. Kansikas,et al. Polymeric Drug Nanoparticles Prepared by an Aerosol Flow Reactor Method , 2004, Pharmaceutical Research.
[189] P York,et al. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. , 2007, Advanced drug delivery reviews.
[190] Y. Kawashima,et al. Properties of a peptide containing DL-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[191] E. Munson,et al. Pure insulin nanoparticle agglomerates for pulmonary delivery. , 2008, Langmuir : the ACS journal of surfaces and colloids.
[192] T. Tan,et al. Preparation of Azithromycin Nanosuspensions by High Pressure Homogenization and its Physicochemical Characteristics Studies , 2007, Drug development and industrial pharmacy.
[193] A. Fahr,et al. Enhanced dissolution of oxcarbazepine microcrystals using a static mixer process. , 2007, Colloids and surfaces. B, Biointerfaces.
[194] K. Moribe,et al. Investigation of Drug Nanoparticle Formation by Co-grinding with Cyclodextrins: Studies for Indomethacin, Furosemide and Naproxen , 2006 .
[195] A. Lundqvist,et al. Particle size reduction for improvement of oral absorption of the poorly soluble drug UG558 in rats during early development , 2009, Drug development and industrial pharmacy.
[196] I. Haririan,et al. Entrapment of 5‐fluorouracil into PLGA matrices using supercritical antisolvent processes , 2011, The Journal of pharmacy and pharmacology.
[197] M. Alonso,et al. Novel hydrophilic chitosan‐polyethylene oxide nanoparticles as protein carriers , 1997 .
[198] Jonghwi Lee,et al. Effective polymeric dispersants for vacuum, convection and freeze drying of drug nanosuspensions. , 2010, International journal of pharmaceutics.
[199] R. Tan,et al. Dry powder aerosol delivery of large hollow nanoparticulate aggregates as prospective carriers of nanoparticulate drugs: effects of phospholipids. , 2007, International journal of pharmaceutics.
[200] C. Arpagaus,et al. Nano and microparticle engineering of water insoluble drugs using a novel spray-drying process. , 2012, Colloids and surfaces. B, Biointerfaces.
[201] A. Fahr,et al. Nano- and micro-particulate formulations of poorly water-soluble drugs by using a novel optimized technique. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[202] K. Cal,et al. Spray drying technique. I: Hardware and process parameters. , 2010, Journal of pharmaceutical sciences.
[203] R. W. Wood,et al. Nebulization of NanoCrystals™: Production of a Respirable Solid-in-Liquid-in-Air Colloidal Dispersion , 2004, Pharmaceutical Research.
[204] Vandana B. Patravale,et al. Current strategies for engineering drug nanoparticles , 2004 .
[205] Po-Chang Chiang,et al. Pharmacokinetic evaluation of a 1,3-dicyclohexylurea nanosuspension formulation to support early efficacy assessment , 2007, Nanoscale Research Letters.
[206] Huibi Xu,et al. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. , 2007, International journal of pharmaceutics.
[207] Ranjita Shegokar,et al. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. , 2010, International journal of pharmaceutics.
[208] P. Constantinides,et al. Advances in lipid nanodispersions for parenteral drug delivery and targeting. , 2008, Advanced drug delivery reviews.
[209] T. Imai,et al. Effect of grinding with hydroxypropyl cellulose on the dissolution and particle size of a poorly water-soluble drug. , 1999, Chemical & pharmaceutical bulletin.
[210] Jong-sang Park,et al. Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- and nanoparticles prepared by high-pressure homogenizer. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[211] S. Feng,et al. Poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy. , 2007, International journal of pharmaceutics.
[212] R. Tan,et al. Novel Formulation of Large Hollow Nanoparticles Aggregates as Potential Carriers in Inhaled Delivery of Nanoparticulate Drugs , 2006 .
[213] R. Müller,et al. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[214] Jean-Michel Kauffmann,et al. The effects of excipients on transporter mediated absorption. , 2010, International journal of pharmaceutics.
[215] W. Nernst,et al. Theorie der Reaktionsgeschwindigkeit in heterogenen Systemen , 1904 .
[216] G. W. Pace,et al. Novel injectable formulations of insoluble drugs , 1999 .
[217] Kikuo Okuyama,et al. Progress in developing spray-drying methods for the production of controlled morphology particles: From the nanometer to submicrometer size ranges , 2011 .
[218] W. Finlay,et al. Fine particle fraction as a measure of mass depositing in the lung during inhalation of nearly isotonic nebulized aerosols , 1997 .
[219] Siling Wang,et al. Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol. , 2011, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[220] Philip Chi Lip Kwok,et al. Production methods for nanodrug particles using the bottom-up approach. , 2011, Advanced drug delivery reviews.
[221] N. Esfandiari. Production of micro and nano particles of pharmaceutical by supercritical carbon dioxide , 2015 .
[222] S. Baumgartner,et al. Advantages of celecoxib nanosuspension formulation and transformation into tablets. , 2009, International journal of pharmaceutics.
[223] Chun Gwon Park,et al. A nanofibrous sheet-based system for linear delivery of nifedipine. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[224] C Olbrich,et al. Formulation of amphotericin B as nanosuspension for oral administration. , 2003, International journal of pharmaceutics.
[225] G. Ji,et al. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation. , 2014, International journal of pharmaceutics.
[226] C. Berkland,et al. Combination Chemotherapeutic Dry Powder Aerosols via Controlled Nanoparticle Agglomeration , 2009, Pharmaceutical Research.
[227] R. Davé,et al. Recovery of BCS Class II drugs during aqueous redispersion of core–shell type nanocomposite particles produced via fluidized bed coating , 2013 .
[228] L. Dong,et al. Nanosizing of a drug/carrageenan complex to increase solubility and dissolution rate. , 2007, International journal of pharmaceutics.
[229] Raviraj Pillai,et al. Production and In Vitro Characterization of Solid Dosage form Incorporating Drug Nanoparticles , 2008 .
[230] K. Byrappa,et al. Nanoparticles synthesis using supercritical fluid technology - towards biomedical applications. , 2008, Advanced drug delivery reviews.
[231] H. Bosch,et al. An in-vitro assessment of a NanoCrystal beclomethasone dipropionate colloidal dispersion via ultrasonic nebulization. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[232] H. Kubo,et al. Improvement of dissolution rate and oral bioavailability of a sparingly water-soluble drug, (+/-)-5-[[2-(2-naphthalenylmethyl)-5-benzoxazolyl]-methyl]- 2, 4-thiazolidinedione, in co-ground mixture with D-mannitol. , 1997, Biological & pharmaceutical bulletin.
[233] E. Merisko-Liversidge,et al. A formulation strategy for gamma secretase inhibitor ELND006, a BCS class II compound: development of a nanosuspension formulation with improved oral bioavailability and reduced food effects in dogs. , 2012, Journal of pharmaceutical sciences.
[234] L. Brannon-Peppas,et al. Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.
[235] R. Tan,et al. The nano spray dryer B-90 , 2011, Expert opinion on drug delivery.
[236] Jennifer Jung,et al. Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes. Part I: Micronization of neat particles. , 2005, International journal of pharmaceutics.
[237] Lei Gao,et al. Drug nanocrystals: In vivo performances. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[238] K. Johnston,et al. Nanoparticle Engineering Processes for Enhancing the Dissolution Rates of Poorly Water Soluble Drugs , 2004, Drug development and industrial pharmacy.
[239] K. Kisich,et al. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. , 2005, American journal of respiratory and critical care medicine.
[240] Robert K. Prud'homme,et al. Flash NanoPrecipitation of Organic Actives and Block Copolymers using a Confined Impinging Jets Mixer , 2003 .
[241] Ludo Froyen,et al. Alternative matrix formers for nanosuspension solidification: Dissolution performance and X-ray microanalysis as an evaluation tool for powder dispersion. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[242] A. Chow,et al. Modification of acetaminophen crystals: influence of growth in aqueous solutions containing p-acetoxyacetanilide on crystal properties , 1985 .
[243] N. Blagden,et al. Hydrocortisone nanosuspensions for ophthalmic delivery: A comparative study between microfluidic nanoprecipitation and wet milling. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[244] E. Munson,et al. Nifedipine nanoparticle agglomeration as a dry powder aerosol formulation strategy. , 2009, International journal of pharmaceutics.
[245] Christos Reppas,et al. Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms , 2004, Pharmaceutical Research.
[246] K. Higashi,et al. Unique indomethacin nanoparticles formation by cogrinding with dextrin under defined moisture conditions , 2012 .
[247] Eric Pridgen,et al. Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.
[248] Elaine Merisko-Liversidge,et al. Nanosizing: a formulation approach for poorly-water-soluble compounds. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[249] Filippos Kesisoglou,et al. Nanosizing--oral formulation development and biopharmaceutical evaluation. , 2007, Advanced drug delivery reviews.
[250] Masoud Bahrami,et al. Production of micro- and nano-composite particles by supercritical carbon dioxide , 2007 .
[251] Jayanth Panyam,et al. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.
[252] R. Müller,et al. Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology. , 2008, International journal of pharmaceutics.
[253] Joo-Youn Cho,et al. Novel nanocrystal formulation of megestrol acetate has improved bioavailability compared with the conventional micronized formulation in the fasting state , 2014, Drug design, development and therapy.
[254] Liang Fang,et al. Preparation and in vitro/in vivo evaluation of revaprazan hydrochloride nanosuspension. , 2011, International journal of pharmaceutics.
[255] Pankaj Pathak,et al. Formation and stabilization of ibuprofen nanoparticles in supercritical fluid processing , 2006 .
[256] Jianfeng Chen,et al. Preparation and characterization of uniform nanosized cephradine by combination of reactive precipitation and liquid anti-solvent precipitation under high gravity environment. , 2005, International journal of pharmaceutics.
[257] Michael Türk,et al. Formation of submicron poorly water-soluble drugs by rapid expansion of supercritical solution (RESS): Results for Naproxen , 2010 .
[258] A. D'emanuele,et al. Solubility enhancement of paclitaxel using a linear-dendritic block copolymer. , 2013, International journal of pharmaceutics.
[259] Sanjay Garg,et al. Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery. , 2009, International journal of pharmaceutics.
[260] S. Kazarian,et al. A novel method for the production of crystalline micronised particles. , 2010, International journal of pharmaceutics.
[261] R. Pandey,et al. Oral solid lipid nanoparticle-based antitubercular chemotherapy. , 2005, Tuberculosis.
[262] T. Asefa,et al. Tailored core-shell-shell nanostructures: sandwiching gold nanoparticles between silica cores and tunable silica shells. , 2007, Langmuir : the ACS journal of surfaces and colloids.
[263] S. Gattani,et al. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability. , 2013, Colloids and surfaces. B, Biointerfaces.